Sofgen Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020
Cash & Equivalents	30.32	17.51	43	72.11	4.23
Cash & Short-Term Investments	30.32	17.51	43	72.11	4.23
Cash Growth	73.10%	-59.27%	-40.37%	1605.18%	107.10%
Accounts Receivable	74.35	120.24	98.33	100.05	88.5
Other Receivables	17.43	16.78	19.92	25.34	19.09
Receivables	92.77	139.3	120.57	125.38	107.89
Inventory	76.54	101.83	99.76	81.56	64.28
Other Current Assets	17.11	17.01	15.97	5.84	8.3
Total Current Assets	216.75	275.65	279.3	284.89	184.7
Property, Plant & Equipment	134.07	137.64	112.98	112.81	113.53
Long-Term Investments	2.31	5.87	1.72	2.7	3.22
Goodwill	-	-	5.79	6.8	6.86
Other Intangible Assets	30.31	42.87	32.18	30.13	27.58
Long-Term Deferred Tax Assets	28.26	10.48	7.49	8.47	21.77
Other Long-Term Assets	-	-	3.08	4.53	1.87
Total Assets	411.69	472.5	442.53	450.33	359.54
Accounts Payable	90.19	87.88	87.23	87.36	97.37
Accrued Expenses	25.86	13.78	3.79	-	2.24
Short-Term Debt	4.42	17.41	15.55	-	0.9
Current Portion of Long-Term Debt	254.42	258.69	246.45	224.32	103.62
Current Portion of Leases	6.53	5.44	9.05	-	10.26
Current Income Taxes Payable	6.71	7.82	6.93	12.29	9.39
Other Current Liabilities	27.81	42.54	17.3	32.31	15.85
Total Current Liabilities	415.92	433.57	386.29	356.28	239.63
Long-Term Debt	17.62	1.3	4.03	29.04	313.2
Long-Term Leases	23.79	29.81	25.14	-	26.54
Pension & Post-Retirement Benefits	4.53	4.46	-	-	-
Long-Term Deferred Tax Liabilities	0.69	2.49	6.75	4.95	18.89
Other Long-Term Liabilities	1.23	1.61	57.46	130.05	15.96
Total Liabilities	463.78	473.24	479.66	520.32	614.22
Common Stock	1.01	1.01	1.01	1.01	2
Additional Paid-In Capital	392.85	375.49	377.68	377.68	54.41
Retained Earnings	-414.14	-346.05	-386.8	-465.89	-287.45
Comprehensive Income & Other	-30.86	-30.25	-28.09	18.15	-24.42
Total Common Equity	-51.14	0.21	-36.2	-69.05	-255.46
Minority Interest	-0.95	-0.95	-0.94	-0.94	0.78
Shareholders' Equity	-52.09	-0.74	-37.13	-69.99	-254.68
Total Liabilities & Equity	411.69	472.5	442.53	450.33	359.54
Total Debt	306.77	312.65	300.22	253.37	454.52
Net Cash (Debt)	-276.46	-295.14	-257.21	-181.25	-450.29
Net Cash Per Share	-2.76	-2.92	-2.54	-1.85	-4.64
Filing Date Shares Outstanding	2,327	2,304	112.82	112.82	2
Total Common Shares Outstanding	112.82	112.82	112.82	112.82	2
Working Capital	-199.18	-157.92	-106.99	-71.39	-54.93
Book Value Per Share	-0.45	0.00	-0.32	-0.61	-127.66
Tangible Book Value	-81.45	-42.66	-74.17	-105.99	-289.9
Tangible Book Value Per Share	-0.72	-0.38	-0.66	-0.94	-144.87
Land	40.76	38.53	32.15	30.32	26.82
Machinery	100.04	95.2	61.84	71.23	69.66
Construction In Progress	16.22	23.39	20.72	9.89	9.33

Source: S&P Global Market Intelligence. Standard template. Financial Sources.